Find a TenderAwardedContract details notice
Published 2 Jun 2025, 14:52 BST

Official UK procurement notice

Appt. of a Contract Manufacturing Organisation for Production of DST-F to GMP

Official notice

Authority: ANIMAL AND PLANT HEALTH AGENCY (Defra Network eTendering Portal)·On behalf of: DEPARTMENT FOR ENVIRONMENT, FOOD AND RURAL AFFAIRS

GoodsCompetitive flexible procedureAbove thresholdSME suitable
Sectors: Medical Devices & Pharma (33) Delivery: UK
Published estimate£9,786,429≈ £1.4m / year · £11,999,999 inc. VAT · 1 value update
Submissions closed 15 Dec 2025awarded 24 Mar 2026
Awarded to Thermo Fisher Scientific Prionic Lelystad B.V2 awards
Contract term 7 yrsends 19 Apr 2033 · up to 19 Apr 2035 with extensions · starts 20 Apr 2026

What is being bought

Published requirement description

A Contract Manufacturing Organisation (CMO) certified to EU Good Manufacturing Practice (GMP) standards is required to work in partnership with the Authority to achieve UK Marketing Authorisation (MA) and, thereafter, for scaled up production of the DST-F product, a diagnostic skin test to Detect Infected among Vaccinated Animals (DIVA). This will involve the technology transfer of the research grade product from the current non-GMP provider and the production of consistency batches.

  • Not divided into lots: Dividing the contract into separate lots has been considered not feasible due to the highly integrated nature of the required services, which include technology transfer, manufacturing, production of consistency batches, quality assurance and control, and regulatory support during the Marketing Authorisation submission process. Fragmentation would introduce significant coordination challenges, increase the risk of quality inconsistency, and complicate the management of interdependent activities. A single-source award is commercially more attractive, offering streamlined delivery, operational efficiency, and clear accountability across all stages of product development and supply.
  • How the procedure runs: This procurement is being conducted as a Competitive Flexible Procedure in accordance with the Procurement Act 2023. Completion and submission of all documents will be conducted via the Authority's eSourcing system. As outlined in 'Part 2 - Procurement Specific Requirements of the Bidder Pack', the Authority reserves the right to conduct negotiations with all participating Tenderers following the completion of Stage 1 - Initial Tender Evaluation. However, Tenderers are strongly advised not to rely on the optional negotiation phase to clarify or introduce critical elements of their submission. Important Notice to Tenderers Initial tender submissions must be clear, complete, and comprehensive, including all relevant information, assumptions, and pricing. The Authority may choose not to proceed to the negotiation stage, and therefore, Tenderers should submit their best possible offer in the first instance. Stage 1 - Initial Tender Stage 1. Procurement Specific Questionnaire- Tenderers must complete a set of questions to enable the Authority to verify core supplier information, exclusions, and debarment status. Responses will be assessed to ensure compliance with all mandatory and discretionary requirements. 2. Conditions of Participation - Responses will be evaluated to confirm that Tenderers meet the minimum capability thresholds. Tenderers failing to meet the minimum capability requirement will be excluded from the procurement process. 3. Tender Evaluation - All compliant tenders will be evaluated in accordance with the scoring methodology detailed in this document and within the Authority's eSourcing platform. Stage 2 - Negotiation Stage (Optional) If the Authority elects to proceed with negotiations: • Tenderers will receive Initial Assessment Summaries, providing high-level feedback on their submissions. • The Authority will issue negotiation details and agenda. • Negotiations will be strictly limited to the topics specified in the Bidder Pack. Stage 3 - Final Tender Stage 1. Invitation to Submit Final Tenders - Following the conclusion of negotiations, Tenderers will be invited to submit their Final Tenders. 2. Clarification Period - A five (5) working day window from date of Invitation to Submit Final Tender will be provided for written clarification questions via Atamis. 3. Final Submission Window - Tenderers will have fourteen (14) working days to resubmit their final tender via Atamis. 4. Final Evaluation - Final tenders will be evaluated using the same Award Criteria. Technical and commercial scores will be combined to determine the Most Advantageous Tender. Tie-Breaker Procedure - In the event of a tie in total scores following evaluation of the Final Tenders, the Authority will apply a tie-breaker to award the contract. This process will only apply to the Tenderers who have the highest overall scoring tenders and will be applied in this listed order; 1) The Tenderer who gained the higher score for E01 'GMP Compliance' will be awarded the contract. 2) If the tie still endures after step 1 the Tenderer who gained the higher commercial score will be awarded the contract.

CPV: Pharmaceutical products

The lotProcurement structure

single lot · value published
Lot #1AwardedRenewal 7 yrsSMEPublished value£9,786,429
Contract period: 20 Apr 2026 – 19 Apr 2033 (7 yrs) · up to 19 Apr 2035 with extensionsValue: £9,786,429 exc. VAT · £11,999,999 inc. VAT
Delivery: LondonEligibility: SME eligible
Extensions: The Contracting Authority may, at its sole discretion, exercise one or more of the following options during the term of the Contract: - Grant a commercial licensing agreement to the successful Supplier for the manufacture and supply of DST-F to Rest of World (RoW) markets, subject to separate agreement and regulatory approvals. - Expand the scope of services to include support for additional Marketing Authorisation applications outside Great Britain. - Increase the volume of DST-F doses required, subject to policy changes and budget availability. These options are provided for in the original procurement and shall be exercised only where they do not substantially alter the nature of the Contract. The Supplier shall be notified in writing of the Authority's intention to exercise any option, and the parties shall agree any contract variations · The Contracting Authority reserves the right to extend the Contract by up to twenty-four (24) months, in increments of twelve (12) months, subject to satisfactory performance and continued operational need. Any extension shall be exercised by giving the Supplier no less than six (6) months' written notice prior to the expiry of the initial term. All terms and conditions shall remain unchanged during the extension period unless otherwise agreed in writing.
Pre-qualification & selection criteria (PQQ)2
  • Economic & financial standing

    As set out in the Bidder Pack.

  • Technical & professional ability

    As set out in the Bidder Pack.

What it takes to win
i

How this buyer will score bids.

The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).

Evaluation split and conditions of participation as published; the tender pack may add more
How bids were scored
Quality: 70%Price: 30%
Published sub-criteria (2)
  • Technical: 70%
  • Commercial: 30%
Published award criteria (2)
  • Technical: As set out in the Bidder Pack.
  • Commercial: As set out in the Bidder Pack.
Conditions of participation2
  • Economic & financial standing

    As set out in the Bidder Pack.

  • Technical & professional ability

    As set out in the Bidder Pack.

What this means for your bid
  • Price carries 30 of 100 points: a 10% discount moves about 3 points. The method statement decides this lot, not the discount.

Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.

Procedure terms & legal framework

From the official record
Procedure method
Competitive flexible procedure
Legal basis
UKPGA · 2023/54 Procurement Act 2023
Procurement category
Goods
Notice status
Awarded
Procurement threshold
Above threshold (FTS publication)
Regulatory regime
Standard
Commercial structure
Stand-alone contract (no framework)
Competition type
Competitive procedure
GPA / WTO covered
Yes (GPA)
Recurring procurement
Unspecified in notice
First published
2 Jun 2025, 14:52 BST
Last source update
9 Jun 2026, 17:25 BST
Award evaluation window
Submission end – 1 Apr 2026
Authority reference
C30459
FTS notice number
2025/S 000-072500
Latest notice
Contract details notice (UK7)
Classification (CPV)
Pharmaceutical products
Delivery area
UK
Official registry OCID
ocds-h6vhtk-052ac4 Find a Tender
How it runs

This procurement is being conducted as a Competitive Flexible Procedure in accordance with the Procurement Act 2023. Completion and submission of all documents will be conducted via the Authority's eSourcing system.

As outlined in 'Part 2 - Procurement Specific Requirements of the Bidder Pack', the Authority reserves the right to conduct negotiations with all participating Tenderers following the completion of Stage 1 - Initial Tender Evaluation. However, Tenderers are strongly advised not to rely on the optional negotiation phase to clarify or introduce critical elements of their submission.

Important Notice to Tenderers

Initial tender submissions must be clear, complete, and comprehensive, including all relevant information, assumptions, and pricing. The Authority may choose not to proceed to the negotiation stage, and therefore, Tenderers should submit their best possible offer in the first instance.

Stage 1 - Initial Tender Stage

  1. Procurement Specific Questionnaire-

Tenderers must complete a set of questions to enable the Authority to verify core supplier information, exclusions, and debarment status. Responses will be assessed to ensure compliance with all mandatory and discretionary requirements.

  1. Conditions of Participation -

Responses will be evaluated to confirm that Tenderers meet the minimum capability thresholds. Tenderers failing to meet the minimum capability requirement will be excluded from the procurement process.

  1. Tender Evaluation -

All compliant tenders will be evaluated in accordance with the scoring methodology detailed in this document and within the Authority's eSourcing platform.

Stage 2 - Negotiation Stage (Optional)

If the Authority elects to proceed with negotiations:

  • Tenderers will receive Initial Assessment Summaries, providing high-level feedback on their submissions.
  • The Authority will issue negotiation details and agenda.
  • Negotiations will be strictly limited to the topics specified in the Bidder Pack.

Stage 3 - Final Tender Stage

  1. Invitation to Submit Final Tenders -

Following the conclusion of negotiations, Tenderers will be invited to submit their Final Tenders.

  1. Clarification Period -

A five (5) working day window from date of Invitation to Submit Final Tender will be provided for written clarification questions via Atamis.

  1. Final Submission Window -

Tenderers will have fourteen (14) working days to resubmit their final tender via Atamis.

  1. Final Evaluation -

Final tenders will be evaluated using the same Award Criteria.

Technical and commercial scores will be combined to determine the Most Advantageous Tender.

Tie-Breaker Procedure -

In the event of a tie in total scores following evaluation of the Final Tenders, the Authority will apply a tie-breaker to award the contract. This process will only apply to the Tenderers who have the highest overall scoring tenders and will be applied in this listed order;

  1. The Tenderer who gained the higher score for E01 'GMP Compliance' will be awarded the contract.
  2. If the tie still endures after step 1 the Tenderer who gained the higher commercial score will be awarded the contract.
Review and risk notes
Risks

Regulatory Risks

  1. Marketing Authorisation Refusal for the Cattle BCG Vaccine;

The Contracting Authority has submitted a Marketing Authorisation (MA) application to the Veterinary Medicines Directorate for the Cattle BCG Vaccine, which is complementary to the DST-F reagent.

Likelihood: Medium

This may result in the deployment of DST-F being significantly delayed or no longer required.

  1. Marketing Authorisation Refusal for DST-F reagent;

Risk that the Marketing Authorisation is refused

Likelihood: Medium

This could impact contract viability and deployment timelines .

Policy and Political Risks

  1. Change in TB policy during contract term

Likelihood: Low

This may affect DST-F demand and contract scope

  1. Impact of Government Spending Review (2026/27 onwards)

Likelihood: Medium

This could affect affordability and budget availability

  1. Farm Trial Specificity Below Expectations
  2. Farm trials may indicate that product specificity is lower than expected. This would not constitute trial failure, but significantly low specificity would require the Authority to undertake a model reassessment and root cause analysis.

Likelihood: Low

This could affect the contract deployment timelines.

How it was run

Official notice
Run through: Defra Group eSourcing
Supplier login requiredElectronic submission allowedLanguage: EN
Access & registration note: Free
Requests to participate (first stage)
12 Nov 2025, 12:00 GMT
Submission deadline
15 Dec 2025, 12:00 GMT
Clarification deadline
15 Dec 2025, 12:00 GMT
Submission channel
Official e-sourcing portal
Electronic submission
Allowed
Accepted languages
en
Detailed submission instructions & authority contactsFrom official release

The procurement documents are available for unrestricted and full direct access, free of charge, at defra-family.force.com/s/Welcome ↗

Any questions, requests to participate or tender submissions must be submitted electronically via this portal.

If you need technical help with the Atamis system, either when registering, or when completing a tender, please contact the Atamis support team e-mail [email protected] or phone Tel: 029 2279 0052.

Timeline

2 Jun 2025 → 9 Jun 2026 · 12 dates
  1. Planning notice published
    2 Jun 2025, 14:52 BST
  2. Market engagement
    16 Jul 2025, 23:59 BST

    Department of Environment, Food and Rural Affairs (Defra) on behalf of Animal and Plant Health Agency (APHA) wishes to inform potential suppliers of an upcoming procurement opportunity and to invite them to participate in early market engagement. The market engagement will consist of; 1. virtual Supplier Briefing Presentation, 2. the issuance of Information pack and Market Engagement Questionnaire (MEQ) and 3. 1:1 Supplier Feedback Sessions to discuss the information provided in the MEQ and further understand supplier capabilities with regard to this requirement. It is important to note that this is not a call for competition. Overview of Requirements: Defra is seeking to appoint a Contract Manufacturing Organisation who will work in partnership with the Authority to achieve UK Marketing Authorisation of the Diva Skin Test – Fusion (DST-F) and, thereafter scale up production for its supply. The services will include:

    • Technical transfer of the DST-F product
    • Production of consistency batches
    • Support the Authority’s Marketing Authorisation submission
    • Commercial manufacture and supply of DST-F to UK upon successfully obtaining Marketing Authorisation
    • Prospective supply to rest of the world, subject to relevant marketing authorisations being achieved Supplier Briefing Presentation: We now invite potential suppliers to a briefing presentation, where we will provide a detailed overview of our requirements and the intended procurement process. This event will be an opportunity for suppliers to gain a better understanding of our needs and to engage with our team. Date: Friday 27th of June 2025 Time: 10:00am Location: Virtual Meeting via the Microsoft Teams Platform How to Participate: Interested suppliers are invited to register their interest in this opportunity via email to: [email protected] using the email title, ‘Contract Manufacturing Organisation for Production of DST-F to GMP Standards - Interested Supplier’. Upon registration, suppliers will receive further details about the Supplier Briefing Presentation Day. Please include the following information in your email:
    • Company name
    • Contact details – email address, preferred person to contact, role or position in company, telephone number
    • Confirm whether you are a GMP manufacturer or not Information Pack and Market Engagement Questionnaire (MEQ): Shortly following the Supplier Briefing Presentation, we will issue an Information document and a Market Engagement Questionnaire to suppliers that registered interest. The purpose of this is to provide suppliers with the information of the upcoming procurement opportunity and invite them to:
    • Provide feedback on Scope/Requirements
    • Provide feedback on the Commercial approach
    • Provide feedback on the proposed Terms and Conditions
    • Provide input into the procurement process Please note due to the sensitive nature of the requirement, all interested suppliers will be required to sign and return an Authority provided Non-Disclosure Agreement in order to participate. The documents are designed to gather valuable input from interested suppliers to inform our procurement strategy and requirements. Timeline:
    • Early Market Engagement Publication: Friday 6th June 2025
    • Registration Deadline: 3pm on Tuesday 24th June 2025
    • Supplier Briefing Presentation: Friday 27th June 2025
    • Information Pack and MEQ Issuance: Monday 30th June 2025
    • MEQ Submission Deadline: 3pm Monday 14th July 2025
    • 1:1 Supplier Feedback Sessions: Wednesday 16th July 2025 Contact Information: For any queries related to this procurement, please contact: Name: Olubunmi Akinmade Position: Senior Commercial Officer Email: [email protected] Thank you for your interest.
  3. Next notice expected380 days ago
    6 Oct 2025, 23:59 BST
  4. Tender notice published345 days ago
    10 Nov 2025, 15:17 GMT
  5. Expressions of interest by343 days ago
    12 Nov 2025, 12:00 GMT
  6. Clarification questions by310 days ago
    15 Dec 2025, 12:00 GMT
  7. Submission deadline310 days ago
    15 Dec 2025, 12:00 GMT
  8. Assessment summaries sent211 days ago
    25 Mar 2026
  9. Award decision expected by203 days ago
    1 Apr 2026, 23:59 BST
  10. Standstill ends197 days ago
    7 Apr 2026, 23:59 BST
  11. Contract starts185 days ago
    20 Apr 2026, 00:00 BST
  12. Latest notice published134 days ago
    9 Jun 2026, 17:25 BST

Notice history

16 events · 8 releases on Find a Tender · since 2 Jun 2025
  1. Pipeline notice published
    2 Jun 2025, 14:52 BST
    UK1
  2. Preliminary market engagement notice published
    6 Jun 2025, 12:35 BST
    UK2
  3. Planned procurement notice published
    5 Sept 2025, 16:16 BST
    UK3
  4. Published value updated to £9,786,429
    5 Sept 2025, 16:16 BST
    was £9,999,999
  5. Procurement method changed
    5 Sept 2025, 16:16 BST
  6. Planned procurement notice published
    5 Sept 2025, 16:28 BST
    UK3
  7. Procurement method changed
    5 Sept 2025, 16:28 BST
  8. Deadline published: 12 Nov 2025, 12:00 GMT
    5 Sept 2025, 16:28 BST
  9. Tender notice published
    10 Nov 2025, 15:17 GMT
    UK4
  10. Status changed to active
    10 Nov 2025, 15:17 GMT
  11. Deadline moved to 15 Dec 2025, 12:00 GMT
    10 Nov 2025, 15:17 GMT
    +33 days · was 12 Nov 2025, 12:00 GMT
  12. Tender notice published
    13 Nov 2025, 12:39 GMT
    UK4
  13. Contract award notice published
    25 Mar 2026, 12:54 GMT
    UK6
  14. Status changed to complete
    25 Mar 2026, 12:54 GMT
  15. Contract signature expected
    10 Apr 2026, 23:59 BST
    scheduled
  16. Contract details notice published
    9 Jun 2026, 17:25 BST
    UK7
Published amendments (2)

Submission Type : Tender not Requests to Participate

Estimated extension end date updated.

Routine re-releases (8)
  • 2025-11: 1 release · 10 Nov 2025
  • 2025-09: 2 releases · 5 Sept 2025, 5 Sept 2025
  • 2025-06: 2 releases · 2 Jun 2025, 6 Jun 2025

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Awards 2
Awarded value £27,677,7841 contract exc. VAT · 1 repeated publication of the same award counted once
Bids received 2
Named bidders 2published on the award notice
Contracts signed 1latest 5 Jun 2026
Awarded toValueDateStatus
Thermo Fisher Scientific Prionic Lelystad B.VAppt. of a Contract Manufacturing Organisation for Production of DST-F to GMP Standard20 Apr 2026 – 19 Apr 2033 · up to 19 Apr 2035Extensions: The Contracting Authority may extend the Contract by up to 24 months in 12‑month increments, with six months’ written notice. All terms remain unchanged unless agreed otherwise in writing. · Options: The Authority may grant the Supplier license DST‑F for Rest‑of‑World supply, expand services for extra Marketing Authorisation applications outside Great Britain, and increase DST‑F volumes if policy or budget changes.£27,677,784same award published again · counted once24 Mar 2026standstill to 7 Apr 2026Standstill
Thermo Fisher Scientific Prionic Lelystad B.V£27,677,784 †—Awarded

Contracts

  • Appt. of a Contract Manufacturing Organisation for Production of DST-F to GMP · Thermo Fisher Scientific Prionic Lelystad B.V

    Signed
    5 Jun 2026
    Value
    £27,677,784
    Period
    8 Jun 2026 – 7 Jun 2033 · up to 7 Jun 2035 with extensions
    Status
    active
    Extensions
    The Contracting Authority may extend the Contract by up to 24 months in 12‑month increments, with six months’ written notice. All terms remain unchanged unless agreed otherwise in writing.
    Options
    The Authority may grant the Supplier license DST‑F for Rest‑of‑World supply, expand services for extra Marketing Authorisation applications outside Great Britain, and increase DST‑F volumes if policy or budget changes.
    3 agreed KPIs: KPI 1.2 - Project Delivery · KPI 1.4 - Consistency batches · KPI 1.5 - Marketing Authorisation Submission
    • KPI 1.2 - Project Delivery, Project Management of technology transfer work including liaison with the Buyer (APHA) and Lionex. Regular reporting ensuring progress against milestones.
    • KPI 1.4 - Consistency batches, Provision of 3 consistency batches and related quality processes i.e. bioassay. All batches received as detailed in planning timescale in the Project Plan
    • KPI 1.5 - Marketing Authorisation Submission, Provision of required part 2 information for MA submission by the agreed delivery dates in Project Plan. Documentation as defined and within timescale agreed further to 1.4.

Bid statistics published by the authority

BidsSMEVCSEValid bid range
2final-stage tenders00—

Who bid

Bidders as named on the Procurement Act 2023 award notice. “Won” means the bidder holds an award on this notice.

Contracting authority & participating public bodies

3 public bodies on the notice

ANIMAL AND PLANT HEALTH AGENCY

Contracting authorityPublic authority - central government GB-PPON: PBHC-6261-BLLQ Seacole Building, 2 Marsham Street, London, London, SW1P 4DFContact name, email

Other public bodies

Bidders & participating suppliers

2 commercial parties on the notice · 1 awarded

Official documents & specifications (9)

Official links; attachments are not copied

Tender pack and attachments

Notices published for this procedure

  • Contract details notice contractContract details noticeUK7Contract details notice on Find a Tender
  • Contract award notice awardContract award noticeUK6Contract award notice on Find a Tender
  • Tender notice tenderTender noticeUK4Tender notice on Find a Tender
  • Tender notice tenderTender noticeUK4Tender notice on Find a Tender
  • Planned procurement notice planningPlanned procurement noticeUK3Planned procurement notice on Find a Tender
  • Planned procurement notice planningPlanned procurement noticeUK3Planned procurement notice on Find a Tender
  • Preliminary market engagement notice planningPreliminary market engagement noticeUK2Preliminary market engagement notice on Find a Tender
  • Pipeline notice planningPipeline noticeUK1Pipeline notice on Find a Tender